Polymerase Chain Reaction (PCR) Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 13.31 Billion |
| Market Size (2029) | USD 19.94 Billion |
| CAGR (2024 - 2029) | 8.42 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Polymerase Chain Reaction (PCR) Market Analysis
The Polymerase Chain Reaction Market size is estimated at USD 13.31 billion in 2024, and is expected to reach USD 19.94 billion by 2029, growing at a CAGR of 8.42% during the forecast period (2024-2029).
The COVID-19 pandemic significantly impacted the polymerase chain reaction market growth. There was a positive impact on the PCR market due to the increasing demand in the clinical diagnostic segment of the market. As the authorities have not recommended viral culture tests, almost all the diagnostic tests use RT-PCR to test the population who had symptoms of COVID-19 were advised by healthcare professionals to undergo a diagnostic test. Most pharmaceutical and biotechnological companies were focusing on the research and development departments on identifying new molecules or leads for the treatment of COVID-19. For instance, in May 2021, Cipla Limited launched 'ViraGen', a polymerase chain reaction (COVID-19 RT-PCR) test for COVID-19 in India in partnership with Ubio Biotechnology Systems Pvt. Ltd. Hence, the COVID-19 pandemic impacted the studied market initially. As the pandemic subsided, fewer PCR tests are being carried out due to which the market has lost some traction that it gained during the pandemic. However, the studied market is expected to have favorable growth over the forecast period of the study.
The major factors driving the growth of the polymerase chain reaction market include the increasing application in clinical diagnostics, rising demand for personalized and precision medicine, and technological advancements and applications in drug development.
The rising demand for personalized and precision medicine is a major factor driving the polymerase chain reaction market growth. For instance, according to an article published by PubMed Central in January 2022, the application of personalized medicine (PM) is said to be rapidly evolving and it has expanded beyond simple genomics. The article also stated that personalized medicines are applied to make medical decisions by integrating daily health, disease characteristic, organ function, environmental, and lifetime exposure data. Furthermore, according to an article published by PubMed in September 2022, digital PCR (dPCR) is a new technology that offers higher precision and other better indicators than the former PCR techniques. The article also stated that dPCR is particularly suited for precision medicine applications that require accurate molecular characterization with high sensitivity. Hence, the rising demand for precision medicines and the increasing adoption of PCR in precision medicine is expected to boost the market growth during the forecast period of the study.
Additionally, technological advancements in molecular biology, life sciences, and biotechnology have brought a paradigm shift in drug discovery, personalized medicines, forensic sciences, and clinical research and development in the biotechnology industry. Polymerase chain reaction (PCR) is an integral part of the pharmaceutical and life science industries, for developing assays, test kits and solutions, and culture media. The rising use of these PCR techniques in disease diagnosis is further fueling market growth. For instance, according to an article published by PubMed Central in July 2022, multiplex PCR has become more and more widely used in the rapid detection of respiratory tract infections as it is relatively cost-saving and can report results within hours, which has become one of the most attractive test methods and currently one of the most commonly used methods in the clinical laboratory.
In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For instance, in August 2022, GenScript USA launched a real-time polymerase chain reaction (RT-PCR) monkeypox test for research lab use. The kit was developed in partnership with Anbio Biotechnology, and it was made available for diagnostic labs and medical device distributors to be used in research to detect the monkeypox virus. Additionally, in September 2022, Bosch launched a new Vivalytic test MRSA/SA for Bosch's Vivalytic platform, thus expanding the test portfolio of this universal PCR system. Hence, these new product launches are expected to boost the growth of the studied market.
Therefore, owing to the factors such as new product launches and strategic activities by major players, technological advancements in molecular biology, life sciences, and biotechnology, and rising demand for personalized and precision medicine, the studied market is anticipated to witness growth over the analysis period. However, the high cost of instruments and the emergence of alternative technologies are the factors hindering the polymerase chain reaction market growth.
Polymerase Chain Reaction (PCR) Market Trends
This section covers the major market trends shaping the Polymerase Chain Reaction Market according to our research experts:
Clinical Diagnostics Segment is Expected to Witness a Significant Growth Over the Forecast Period
The clinical diagnostics segment is expected to witness significant growth over the forecast period. PCR has become an integral part of clinical diagnosis over the years. PCR helps reduce diagnosis time and has improved the specificity and accuracy of clinical diagnostic tests. Hence, factors such as the increasing adoption of PCR in clinical diagnostics and the rising prevalence of infectious diseases such as HIV/AIDS are driving the segment's growth.
According to an article updated by NCBI in May 2022, PCR is considered a laboratory technique that is utilized to amplify specific segments of DNA for a wide range of laboratory and/or clinical diagnostic applications. The article further stated that PCR amplification has various applications within medicine, such as being used to test for the presence of specific alleles in the case of prospective parents screening for genetic carriers; it can also be used to diagnose the presence of disease directly and for mutations in the developing embryo.
Also, the rising prevalence of infectious diseases is expected to enhance the segment's growth. For instance, as per the data by UNAIDS in 2022, an estimated 38.4 million people globally were living with HIV in 2021, and 1.5 million people became newly infected with HIV in 2021. Hence, the rising prevalence of infectious diseases around the world is expected to enhance segment growth, as PCR plays an important role in the diagnosis of diseases.
The growth of this market segment is also helped by the introduction of new products.For instance, in August 2022, Molbio Diagnostics launched a new test named the Trunet RT-PCR test for the differential diagnosis of HIV-1 and HIV-2 with viral loads within 60 minutes. Such launches also propel the growth of the market segment.
Thus, factors such as the increasing adoption of PCR in clinical diagnostics, the rising prevalence of infectious diseases such as HIV, and the launch of new products are expected to enhance the segment's growth during the forecast period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
The North America segment is growing because there are a lot of manufacturers in the market, there are more genetic and chronic diseases like cancer, the population is getting older, people want more precise and personalized medicine, and the government is doing things to help.
For instance, according to data from the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Furthermore, according to the data updated by the CDC in November 2022, it is estimated that from October 2022 to November 2022 there have been 2,800,000-6,600,000 flu-related illnesses, 1,400,000-3,300,000 flu-related medical visits, and 23,000-48,000 flu-related hospitalizations in the United States. Moreover, according to the data published by Statistics Canada in collaboration with the Canadian Cancer Society and the Public Health Agency of Canada in June 2022, an estimated 233,900 people in Canada will be diagnosed with cancer during 2022. Hence, the rising prevalence of such diseases is poised to increase the adoption of PCR, thus enhancing market growth during the forecast period of the study.
Furthermore, the launch of new products based on PCR tests will drive the market's growth significantly. For instance, in November 2022, Roche introduced the Cobas 5800 System in the United States. It is a compact, fully-automated molecular laboratory instrument that offers a flexible PCR testing solution that aids clinicians in the diagnosis of infectious diseases. Furthermore, in May 2021, the United States FDA approved the TheraScreen KRAS RGQ PCR Kit by Qiagen, a laboratory test that detects seven mutations found in the KRAS gene of non-small cell lung cancer and colorectal cancer.
Thus, in view of factors such as the increasing prevalence of genetic and chronic disorders and the launch of new products based on PCR tests, the market is expected to witness significant growth in the region over the forecast period.
Polymerase Chain Reaction (PCR) Industry Overview
The market studied is moderately consolidated in nature, owing to the presence of a few major players. Some of the market players are Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation, Siemens Healthcare, and Thermo Fisher Scientific Inc. These major companies in the market are engaging in partnerships, mergers, and acquisitions, aiming to strengthen their product portfolios and manufacturing capacities and provide competitive differentiation.
Polymerase Chain Reaction (PCR) Market Leaders
-
Abbott Laboratories
-
Agilent Technologies Inc.
-
Thermo Fisher Scientific Inc.
-
Siemens Healthineers
-
BioMerieux SA
*Disclaimer: Major Players sorted in no particular order
Polymerase Chain Reaction (PCR) Market News
- November 2022: Cepheid launched Xpert Xpress MVP, a multiplexed PCR test that detects DNA from organisms associated with three distinct conditions: bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis, from a single sample, aiding in more accurate diagnosis and antibiotic treatment regimens.
- November 2022: PCR Biosystems launched a new family of qPCR reagent mixes: Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix.
Polymerase Chain Reaction (PCR) Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Application in Clinical Diagnostics
- 4.2.2 Rising Demand for Personalized and Precision Medicines
- 4.2.3 Technological Advancements and Applications in Drug Development
-
4.3 Market Restraints
- 4.3.1 High Cost of Instruments
- 4.3.2 Emergence of Alternative Technologies
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value -USD million)
-
5.1 By Product
- 5.1.1 Instruments
- 5.1.1.1 Standard PCR Systems
- 5.1.1.2 Digital PCR Systems
- 5.1.1.3 Real-time PCR Systems
- 5.1.2 Reagents and Consumables
- 5.1.3 Software
-
5.2 By Application
- 5.2.1 Clinical Diagnostics
- 5.2.2 Life Science Research and Industrial Applications
- 5.2.3 Other Applications
-
5.3 By End User
- 5.3.1 Academic Institutes
- 5.3.2 Clinical Diagnostics Labs and Hospitals
- 5.3.3 Pharmaceutical and Biotechnology Industries
- 5.3.4 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 Agilent Technologies Inc.
- 6.1.3 Becton, Dickinson and Company
- 6.1.4 bioMerieux SA
- 6.1.5 Bio-Rad Laboratories Inc.
- 6.1.6 Merck KGaA
- 6.1.7 PerkinElmer Inc.
- 6.1.8 Promega Corporation
- 6.1.9 Siemens Healthcare
- 6.1.10 Thermo Fisher Scientific Inc.
- 6.1.11 Danaher Corporation
- 6.1.12 QIAGEN
- 6.1.13 QuantuMDx Group Ltd
- 6.1.14 Eppendorf
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityPolymerase Chain Reaction (PCR) Industry Segmentation
According to the scope of this report, polymerase chain reaction (PCR) is a method used to make thousands to millions of copies of a certain DNA segment by amplifying target DNA. PCR techniques are used in clinical and research laboratories for a broad variety of applications, which include clinical diagnosis, criminal forensics, and biomedical research. The Polymerase Chain Reaction Market is Segmented by Product (Instruments, Reagents and Consumables, and Software), Application (Clinical Diagnostics, Life Science Research, Industrial Applications, and Other Applications), End User (Academic Institutes, Clinical Diagnostics Labs and Hospitals, Pharmaceutical and Biotechnology Industries, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | Instruments | Standard PCR Systems |
| Digital PCR Systems | ||
| Real-time PCR Systems | ||
| By Product | Reagents and Consumables | |
| Software | ||
| By Application | Clinical Diagnostics | |
| Life Science Research and Industrial Applications | ||
| Other Applications | ||
| By End User | Academic Institutes | |
| Clinical Diagnostics Labs and Hospitals | ||
| Pharmaceutical and Biotechnology Industries | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Polymerase Chain Reaction (PCR) Market Research FAQs
How big is the Polymerase Chain Reaction Market?
The Polymerase Chain Reaction Market size is expected to reach USD 13.31 billion in 2024 and grow at a CAGR of 8.42% to reach USD 19.94 billion by 2029.
What is the current Polymerase Chain Reaction Market size?
In 2024, the Polymerase Chain Reaction Market size is expected to reach USD 13.31 billion.
Who are the key players in Polymerase Chain Reaction Market?
Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Siemens Healthineers and BioMerieux SA are the major companies operating in the Polymerase Chain Reaction Market.
Which is the fastest growing region in Polymerase Chain Reaction Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Polymerase Chain Reaction Market?
In 2024, the North America accounts for the largest market share in Polymerase Chain Reaction Market.
What years does this Polymerase Chain Reaction Market cover, and what was the market size in 2023?
In 2023, the Polymerase Chain Reaction Market size was estimated at USD 12.28 billion. The report covers the Polymerase Chain Reaction Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Polymerase Chain Reaction Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
PCR Industry Report
The Global Polymerase Chain Reaction (PCR) Market is experiencing significant growth, driven by advancements in clinical diagnostics, life science research, and industrial applications. The market is segmented by product into instruments, reagents and consumables, and software. Additionally, the market is categorized by application into clinical diagnostics, life science research, industrial applications, and other applications, and by end user into academic institutes, clinical diagnostics labs and hospitals, pharmaceutical and biotechnology industries, and other end users.
The industry report provides a comprehensive market analysis, including market share, market size, and market growth. The market research highlights the industry trends and market forecast, offering a detailed industry overview. The market leaders in the PCR market are identified, and the industry statistics support the market predictions and market outlook.
The report example includes a market review and market segmentation, providing valuable industry information. The market value and industry sales are analyzed, and the industry outlook is discussed in detail. The market data is presented in a report PDF, which can be downloaded for further analysis.
This industry research covers the market trends and market growth, offering insights into the industry size and industry reports. The market forecast and market overview provide a clear understanding of the market dynamics. The research companies involved in the PCR market are also highlighted, contributing to the overall industry analysis. The report includes a growth rate analysis, supporting the market predictions and market segmentation. The industry information and industry research are essential for understanding the market value and market data.
Overall, the Global Polymerase Chain Reaction (PCR) Market report provides a thorough market review, supported by industry statistics and market outlook. The report PDF serves as a valuable resource for understanding the market trends and market growth, offering a comprehensive industry analysis and market forecast.
